BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31656675)

  • 1. Elevation of pulmonary CD163
    Nouno T; Okamoto M; Ohnishi K; Kaieda S; Tominaga M; Zaizen Y; Ichiki M; Momosaki S; Nakamura M; Fujimoto K; Fukuoka J; Shimizu S; Komohara Y; Hoshino T
    J Thorac Dis; 2019 Sep; 11(9):4005-4017. PubMed ID: 31656675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Profiles of CD163-Positive Macrophages in Idiopathic Interstitial Pneumonias.
    Yamashita M; Saito R; Yasuhira S; Fukuda Y; Sasamo H; Sugai T; Yamauchi K; Maemondo M
    J Immunol Res; 2018; 2018():1436236. PubMed ID: 29507864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating M2-like monocytes in patients with breast cancer.
    Zhang B; Cao M; He Y; Liu Y; Zhang G; Yang C; Du Y; Xu J; Hu J; Gao F
    Tumour Biol; 2017 Jun; 39(6):1010428317711571. PubMed ID: 28639912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.
    Higashi-Kuwata N; Jinnin M; Makino T; Fukushima S; Inoue Y; Muchemwa FC; Yonemura Y; Komohara Y; Takeya M; Mitsuya H; Ihn H
    Arthritis Res Ther; 2010; 12(4):R128. PubMed ID: 20602758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD163 is produced by monocyte-derived and alveolar macrophages, and is not associated with the severity of idiopathic pulmonary fibrosis.
    Chauvin P; Morzadec C; de Latour B; Llamas-Gutierrez F; Luque-Paz D; Jouneau S; Vernhet L
    Innate Immun; 2022 Apr; 28(3-4):138-151. PubMed ID: 35522300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum macrophage-mannose receptor CD206 with mortality in idiopathic pulmonary fibrosis.
    Zou R; Gui X; Zhang J; Tian Y; Liu X; Tian M; Chen T; Wu H; Chen J; Dai J; Cai H
    Int Immunopharmacol; 2020 Sep; 86():106732. PubMed ID: 32622200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M1- and M2-macrophage polarization in thioacetamide (TAA)-induced rat liver lesions; a possible analysis for hepato-pathology.
    Wijesundera KK; Izawa T; Murakami H; Tennakoon AH; Golbar HM; Kato-Ichikawa C; Tanaka M; Kuwamura M; Yamate J
    Histol Histopathol; 2014 Apr; 29(4):497-511. PubMed ID: 24127400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma.
    Komohara Y; Horlad H; Ohnishi K; Ohta K; Makino K; Hondo H; Yamanaka R; Kajiwara K; Saito T; Kuratsu J; Takeya M
    J Clin Exp Hematop; 2011; 51(2):93-9. PubMed ID: 22104307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation.
    Stahl M; Schupp J; Jäger B; Schmid M; Zissel G; Müller-Quernheim J; Prasse A
    PLoS One; 2013; 8(11):e81382. PubMed ID: 24278429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of tumor-infiltrating macrophages, M2 macrophages, regulatory T-cells, and indoleamine 2,3-dioxygenase-positive cells in primary diffuse large B-cell lymphoma of the central nervous system.
    Nam SJ; Kim S; Kwon D; Kim H; Kim S; Lee E; Kim TM; Heo DS; Park SH; Lim MS; Kim CW; Jeon YK
    Oncoimmunology; 2018; 7(7):e1442164. PubMed ID: 29900049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nakamura T; Nishio M; Watajima T; Kuroda D; Komori T; Kakeji Y; Semba S; Yokozaki H
    Cancer Sci; 2013 Aug; 104(8):1112-9. PubMed ID: 23648122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer.
    Miyasato Y; Shiota T; Ohnishi K; Pan C; Yano H; Horlad H; Yamamoto Y; Yamamoto-Ibusuki M; Iwase H; Takeya M; Komohara Y
    Cancer Sci; 2017 Aug; 108(8):1693-1700. PubMed ID: 28574667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
    Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
    Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages.
    Uhal BD; Kim JK; Li X; Molina-Molina M
    Curr Pharm Des; 2007; 13(12):1247-56. PubMed ID: 17504233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-Derived Suppressor Cells and CD68
    Lv M; Zhuang X; Shao S; Li X; Cheng Y; Wu D; Wang X; Qiao T
    J Immunol Res; 2022; 2022():3621496. PubMed ID: 35928634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
    Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
    Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.
    Enomoto N; Oyama Y; Enomoto Y; Mikamo M; Karayama M; Hozumi H; Suzuki Y; Kono M; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Clin Respir J; 2018 Aug; 12(8):2378-2389. PubMed ID: 29873202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody combinations for optimized staining of macrophages in human lung tumours.
    Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis.
    Khalil N; Parekh TV; O'Connor R; Antman N; Kepron W; Yehaulaeshet T; Xu YD; Gold LI
    Thorax; 2001 Dec; 56(12):907-15. PubMed ID: 11713352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.